Latest News

Researchers Improve Breast Cancer Risk Assessment Model
A significant increase in breast cancer development was found among a specific subset of women.
Recent developments in cancer treatment and research.
Beta-blockers found reduce to stress from hormones that fuel disease progression.
Study may help improve early cancer detection.
Researchers evaluate the benefits of subcutaneous methotrexate compared with the oral version.
Higher levels of physical activities leads to lower MS relapse rates.
Study estimates United States is wasting $45 million every month that biosimilar Zarxio is not on the market.
Top stories of the week on Specialty Pharmacy Times.


2015 Specialty Trend in Senior Care
Significant growth has been seen in specialty medication use in long-term care facilities.
Pharmacy stakeholders must be nimble and responsive to innovations and disruptive trends in the market.
The transition in specialty pharmacy from traditional prescription ordering processes to e-prescribing brings challenges and benefits.
NASP promotes collaboration among specialty pharmacy stakeholders, emphasizing the importance of education and advocacy.
Pharmacy stakeholders who work with electronic health care data need to be vigilant against security breaches.
PCSK9 inhibitors are about to make their debut, and specialty pharmacy is poised to play a key role in their management.


Marc O'Connor, Chief Operating Officer of Curant Health, discusses the potential impact of biosimilars on the specialty drug market.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses URAC specialty practice standards.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses whether the R&D cost for biosimilars will affect the overall cost reduction.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses takeaways from the impact of high cost drug launches on specialty pharmacy.

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributor >
Industry Guide >
Market News >
Peer Exchange >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2015
Intellisphere, LLC. All Rights Reserved.